相关实验视频
Updated: Jul 17, 2025

07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
10.3K
婴儿和幼儿胆固醇病的治疗方法
Nicole Heinz1, Jennifer Vittorio2
1New York University (NYU) Transplant Institute, NYU Langone Health, 160 East 32nd Street, Suite L3 Medical Level, New York, NY, USA.
Current gastroenterology reports
|August 31, 2023
概括
基因检测,就像下一代测序一样,有助于早期诊断肝脏疾病胆固醇症. 针对胆酸运输的新疗法为患有遗传胆固醇状况的患者提供了改善的管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学遗传学 医学遗传学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇症的特征是结合性高白血症,这意味着胆汁的流动受损,并可能表明严重的潜在疾病.
- 及时诊断对于管理与胆固醇症相关的肝胆,遗传或代谢疾病至关重要.
研究的目的:
- 审查胆固醇形成的评估.
- 突出目前和新兴的胆固醇性疾病治疗策略.
主要方法:
- 审查关于胆固醇病的诊断和治疗的当前文献.
- 专注于基因测试和新型治疗方法的影响.
主要成果:
- 下一代测序 (NGS) 促进了早期遗传测试,可能改变胆固醇性疾病的诊断算法.
- 皮质胆汁酸载体 (IBAT) 抑制剂已被批准用于特定遗传条件下的胆固醇性,代表了向治疗.
- 了解病理生理学指导突变特异性治疗的开发.
结论:
- 基因诊断和向疗法的进步正在改变胆固醇病的管理.
- 快速的病因诊断对于利用新的治疗方式和改善患者的治疗结果至关重要.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Prevention of Further Absorption of Poison
851
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
851
Esophageal Varices-II: Clinical Features and Management
94
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
94
Diseases of the Liver and Gallbladder
622
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
622
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194

